Photo: iStockphotoNew Delhi: India could have a vaccine for the dreaded dengue as early as end 2019, according to drug maker Panacea Biotec, which has secured permission to conduct clinical trials for the vaccine in India. “As dengue is a big challenge for India and a vaccine is direly required, we have given a go-ahead for trials for dengue vaccine by TDB and Panacea Biotec,” said G.N. Panacea Biotec, in collaboration with the National Institutes of Health (NIH), US, has developed the advanced dengue vaccine with proven safety in pre-clinical studies. “An efficient dengue vaccine must provide a balanced immune response against all four serotypes in all age groups, ideally in a single-dose regimen. The new dengue vaccine development programme would, therefore, represent a major advancement in the control of this life-threatening disease globally,” Rajesh Jain, joint managing director of Panacea Biotec, said in a statement.

Source: Mint November 24, 2017 19:07 UTC